چکیده انگلیسی مقاله |
Background: About 20% of patients with coronavirus disease 2019 (COVID-19) present with mucocutaneous eruptions. Early skin or dermatological manifestations can help pediatricians prevent the spread of the disease by suspecting COVID-19 in asymptomatic or minimally symptomatic patients. Methods: PubMed, Scopus, Embase, Google Scholar, and the Nottingham University website were searched on Sep. 1st, 2020, to retrieve studies regarding COVID-19-related mucocutaneous manifestations in patients under the age of 18. Results: Data were extracted from 76 articles including 38,387 cases. Chilblain/pernio-like lesions were the most common dermatological manifestation, followed by multisystem inflammatory syndrome in children (MIS-C)/Kawasaki-like syndrome. Most dermatological signs were self-limited, presenting before, simultaneously with, or after other COVID-19 manifestations. In 40% of the affected children, these signs were the sole presentation of COVID-19. Conclusion: During the COVID-19 pandemic, each new mucocutaneous event in children, especially acral lesions with vascular color, should be considered a possible indicator of COVID-19.
|
کلیدواژههای انگلیسی مقاله |
COVID-19,SARS-CoV-2,mucocutaneous manifestation,dermatologic manifestation,Cutaneous manifestation,Pediatric,children |
نویسندگان مقاله |
Farnoosh Seirafianpour | Student Research Committee, School
of Medicine, Iran University of Medical
Sciences, Tehran, Iran
Farzaneh Mashayekhi | Department of General Medicine, Rasool Akram Medical Complex, Iran University of Medical Sciences (IUMS), Tehran, Iran
Milad Dodangeh | Student Research Committee, School of Medicine, Iran University of Medical Sciences, Tehran, Iran
Forough Seifi Gharabaghloo | Department of General Medicine, Rasool Akram Medical Complex, Iran University of Medical Sciences (IUMS), Tehran, Iran
Masoud Pourghahramani Koltapeh | Student Research Committee, School of Medicine, Iran University of Medical Sciences, Tehran, Iran
Ali Jamshidi Naeini | Student Research Committee, School of Medicine, Iran University of Medical Sciences, Tehran, Iran
Rohollah Valizadeh | Urmia University of Medical Sciences,
Urmia, Iran
Davood Lakestani | Department of Pediatrics, Imam Hossein
Hospital, Shahid Beheshti University of
Medical Sciences, Tehran, Iran
Samaneh Mozafarpoor | Department of Dermatology, Skin Disease
and Leishmaniasis Research Center,
Isfahan University of Medical Sciences,
Isfahan, Iran
Azadeh Goodarzi | Department of Dermatology, Rasool
Akram Medical Complex Clinical
Research Development Center (RCRDC),
School of Medicine, Iran University of
Medical Sciences, Tehran, Iran
|